| Literature DB >> 29470790 |
Isabelle Roth1,2, Stephan Schumacher3, Tina Basler4, Kathrin Baumert5, Jan-Marten Seitz6, Florian Evertz7, Peter Paul Müller8, Wolfgang Bäumer9, Manfred Kietzmann1.
Abstract
Magnesium is currently under investigation as a prospective biodegradable implant material. Biodegradation of magnesium causes a release of magnesium, hydroxide ions and hydrogen gas but it can also lead to the formation of particulate debris. Implant-derived particles may have immunotoxic effects. To investigate the influence of magnesium-derived particles on the immune functions of primary macrophages, up to 500 μg/ml magnesium or magnesium corrosion particles were added to the cell culture medium. No major effects were observed on cell viability and on the release of the proinflammatory cytokine tumor necrosis factor (TNF)α. In addition, the ability of macrophages to stimulate proliferation of allogenic lymphocytes in a mixed leukocyte reaction remained unaffected. When macrophages were incubated with magnesium particles and then infected with the apathogenic Mycobacterium smegmatis, infection-induced TNFα secretion from murine macrophages was inhibited but not from human macrophages. However, the bactericidal activity of either cell type was not influenced. In conclusion, magnesium-related particles did not restrict the immune function of macrophages, suggesting that magnesium implants and corrosion particles derived thereof are highly biocompatible and have a low inflammatory potential.Entities:
Keywords: Degradation; Immunotoxic; In vitro; Infection; Inflammation; Phagocytes
Year: 2014 PMID: 29470790 PMCID: PMC5151114 DOI: 10.1007/s40204-014-0032-9
Source DB: PubMed Journal: Prog Biomater ISSN: 2194-0517
Fig. 1SEM images of particles. Scanning electron microscopy images of Mg particles (a), magnesium corrosion particles (b) and CCM particles (c) at 200× (a, b) or 2500× (c) magnification, respectively
Fig. 2Biocompatibility of particles. Murine or human macrophages were incubated for 24 h with media containing indicated amount of magnesium particles (Mg), magnesium corrosion particles (MCP) or cobalt–chromium–molybdenum particles (CCM). Untreated cells served as a control (Co). a Metabolic activity, mean ± SD of n = 3–6. b Metabolic activity, mean ± SD of n = 8. c TNFα concentration, mean ± SD of n = 7. ANOVA, ** p < 0.01, *** p < 0.001 compared to control cells
Magnesium concentration of treatment supernatants
| Treatment (μg/ml) | Mg | MCP | ||||||
|---|---|---|---|---|---|---|---|---|
| 20 | 50 | 100 | 500 | 20 | 50 | 100 | 500 | |
| Magnesium conc. (mM) | 0.5 ± 0.2 | 1.2 ± 0.5 | 2.6 ± 0.6 | 10.8 ± 2.8 | 0.4 ± 0.3 | 0.6 ± 0.6 | 1.7 ± 1.9 | 3.6 ± 0.5 |
Magnesium concentration of supernatants after treatment with particle media containing indicated amount of magnesium-based particles, Mean ± SD of n = 3
Fig. 3TNFα release from infected macrophages. Murine or human macrophages were incubated for 24 h with media containing either no particles (Co) or indicated amount of magnesium particles (Mg), magnesium corrosion particles (MCP) or cobalt–chromium–molybdenum particles (CCM) before infection with Mycobacterium smegmatis. Particle incubation was then continued for further 20 h. a Mean ± SD of n = 6–8. b Mean ± SD of n = 5. ANOVA, *p < 0.05 compared to untreated control cells. Changes in panel b were not statistically significant
Fig. 4Mixed leukocyte reaction. Murine macrophages were treated for 24 h with media containing 100 μg/ml of indicated particles or media without particles before having been incubated with CFSE-stained lymphocytes. Representative histograms of three independent experiments showing percentage of proliferated cells
Mixed leukocyte reaction
| Treatment | Control (untreated) | Mg | MCP | CCM |
|---|---|---|---|---|
| Proliferated cells (%) | 62.7 ± 0.9 | 65.2 ± 2.0 | 66.6 ± 5.7 | 66.0 ± 4.2 |
Proliferated lymphocytes after coincubation with particle-treated macrophages, Mean ± SD of n = 3
Fig. 5Absence of mycobacterial growth. Human macrophages were incubated for 24 h with media containing indicated amount of particles before infection with Mycobacterium smegmatis. Particle incubation was then continued for further 20 h before cells were lysed, seeded on Lysogeny broth agar plates and incubated for 6 days. Panel a shows growth of Mycobacterium smegmatis. The plate in panel b is representative of at least five independent experiments using human or murine macrophages, respectively. No colony-forming units were observed in any of the experiments after any particle treatment